Article Text
Extended Report
A multicenter double-blind randomized placebo-controlled trial of Kineret® (anakinra), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate therapy
Statistics from Altmetric.com
This is a PDF-only article. The first page of the PDF of this article appears above.